emergency-sign-at-hospital-300x201-7290191Some New York hospitals are commanding far higher prices than their regional competitors, and market leverage – not quality or demographic factors – is the most likely explanation, according to an important new study from the New York State Health Foundation.

The most expensive hospitals are being paid 1.5 to 2.7 times more than the lowest-priced hospitals in their areas, the study found. The higher-cost facilities did not consistently deliver better quality of care, treat sicker patients, or have the prestige of being an academic medical center.

“Hospitals with higher prices do not necessarily have higher quality,” the report says. “Likewise, hospitals with lower prices do not necessarily have lower quality.”

There is a statistical correlation between higher prices and a hospital’s market leverage, the authors found: Hospitals that controlled a large market share, or were members of broad systems, or were the only local providers in rural areas tended to receive bigger payments.

The findings suggest that a wave of consolidation has given some hospitals too much bargaining clout in negotiations with insurers. The authors also link the disparities to a lack of transparency in hospital pricing and contracting practices that prevent health plans from steering customers to affordable providers.

The study questions the idea that hospitals negotiate for higher prices to offset the lower reimbursements they get from government-sponsored health plans. In general, hospitals treating more Medicare and Medicaid patients charged lower prices, while hospitals treating fewer Medicaid and Medicaid patients charged more.

Hospitals account for about 40 percent of overall healthcare spending, the study said.

The report, prepared by a team led by Gorman Actuarial Inc. of Massachusetts, analyzed the pricing of 107 hospitals in the New York City, Albany, and Buffalo regions, using non-public data obtained from nine insurers under an order by the Department of Financial Services.

The study recommends policy changes aimed at boosting the competitiveness of New York’s hospital market, such as making hospital pricing details more readily available to the public and barring contract provisions that block insurers from steering customers to lower-cost institutions.

The study is modeled on research by the Massachusetts Attorney General’s Office in 2010, which documented similar disparities in hospital pricing. The findings prompted Bay State lawmakers to gather and publicize more data on hospital pricing, establish a target growth rate for overall healthcare spending, and sanction facilities whose costs rise too fast.

For more on the Health Foundation’s study on hospital pricing, see coverage by the Times Union and Modern Healthcare.

 

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

Inflation Trends in the New York Metropolitan Area

Federal data show that prices in the New York metropolitan area are not only high, but rising faster than the national average. According to the Bureau of Labor Statistics, the Consumer Price Index for the New York–Newark–Jersey City area ro Read More

Albany Should Listen to Jamie Dimon

In his annual message to shareholders, JP Morgan Chase's chief executive, Jamie Dimon, offered a timely and pointed warning for New York policymakers. It's worth , with emphasis add Read More

Albany Wavers on Shutting Down a Medicaid Racket

As Washington threatens to crack down on fraud and abuse in New York's Medicaid program, state legislators are doing their best to demonstrate why federal intervention is needed. A Read More

Getting to the Bottom of the 340B Drug Discount Boondoggle

Some of New York's largest and most prosperous hospitals are reporting rapidly growing amounts of revenue from pharmacy sales – most of it apparently flowing from a controversial drug discount program known as 340B. Read More

New York Still Hasn’t Learned from its Covid Mistakes

Today marks the sixth anniversary of a fateful moment in New York's coronavirus pandemic: the Cuomo administration's order sending Covid-infected patients into nursing homes. Of the Read More

Ideas for Cleaning Up New York Medicaid

As the Trump administration cracks down on fraud, waste and abuse in Medicaid, New York is a logical place to start. New York spends far more Read More

The Bottom Line of Hochul’s Essential Plan Overhaul

Now that New York has won partial federal approval for overhauling its Essential Plan, it's worth being clear about what the state is doing and why. The is not primarily about "pre Read More

Emails Conflict with Health Commissioner’s Testimony on CDPAP

The company selected to manage an $11 billion Medicaid home-care program discussed the job in detail with top Health Department officials – and submitted a 46-page takeover plan – two weeks before state lawmakers author Read More